Benzimidazole and Imidazole Derivatives
Benzimidazole is a compound consisting of a benzene ring fused to an imidazole ring, a five-membered structure containing two nitrogen atoms. Benzimidazole derivatives, such as albendazole, are known for their antiparasitic and antifungal activity, used in the treatment of parasitic infections and certain parasitic diseases in animals and humans. Imidazole, on the other hand, is a five-membered structure with two nitrogen atoms found in various biologically active compounds. Imidazole derivatives, such as metronidazole, have antimicrobial and antiparasitic properties. These compounds are also used in the pharmaceutical industry for treating bacterial infections, parasitic diseases, and some fungal infections, as well as in organic chemistry as catalysts.
At CymitQuimica, we offer high-purity benzimidazoles and imidazoles for research in medicinal chemistry, pharmacology, and biotechnology.
Found 10376 products of "Benzimidazole and Imidazole Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
rac-Pregabalin
CAS:Controlled Product<p>Applications A GABA analogue used as an anticonvulsant.Controlled substance in the United States.Not controlled in Germany<br>References Taylor, C.P., at al.: Epilepsy Res., 14, 11 (1993), Field, M.J., et al.: Pain, 80, 391 (1999)<br></p>Formula:C8H17NO2Color and Shape:White SolidMolecular weight:159.23Albendazole Sulfoxide
CAS:<p>Impurity Albendazole EP Impurity B<br>Applications Albendazole Sulfoxide (Albendazole EP Impurity B) is a metabolite of Albendazole, an anthelmintic.<br>References Dominguez, L., et al.: Farmaco, 50, 697 (1995), De Laurentis, N., et al.: Pharm. Pharmacol Lett., 6, 2: 51 (1996)<br></p>Formula:C12H15N3O3SColor and Shape:White To BrownMolecular weight:281.33Lansoprazole Sulfone
CAS:<p>Impurity Lansoprazole USP Related Compound A<br>Applications A metabolite of Lansoprazole, as gastric pump inhibitor. Lansoprazole USP Related Compound A.<br>References De Morais, S., et al.: Mol. Pharmacol., 46, 594 (1994), Spencer, C., et al.: Drugs, 48, 404 (1994), Pearce, R., et al.: J. Pharmacol. Exp. Ther., 277, 805 (1996), Tassaneeyakul, W., et al.: Br. J. Clin. Pharmacol., 49, 139 (2000),<br></p>Formula:C16H14F3N3O3SColor and Shape:NeatMolecular weight:385.363a,4,5,6-Tetrahydro Midazolam
CAS:Controlled Product<p>Applications 3a,4,5,6-Tetrahydro Midazolam is an impurity of Midazolam (M343000), a drug used for the treatment of acute seizures and is also known to exhibit activities as an anticonvulsant, sedative, and hypnotic.<br>References Dundee, J. W., et al.: Drugs, 28, 519 (1984); Lahat, E., et al.: Br. Med. J., 321, 83 (2000); Sati, B., et al.: Acta Pharm., 63, 385 (2013);<br></p>Formula:C18H17ClFN3Color and Shape:NeatMolecular weight:329.80Apoatropine Hydrochloride
CAS:<p>Applications Apoatropine is an alkaloid derivative with the potential to be an antibacterial.<br>References Cherkaoui, S. et al.: Electrophor., 19, 2900 (1998); Marrero-Ponce, Y. et al.: Bioorg. Med. Chem., 13, 2881 (2005);<br></p>Formula:C17H21NO2·ClHColor and Shape:White To Off-WhiteMolecular weight:307.824-Hydroxy Omeprazole Sulfide
CAS:Controlled Product<p>Stability Light Sensitive<br>Applications An intermediate in the preparation of Omeprazole metabolites.<br>References Hoffmann, K., et al.: Drug Metab. Disposition, 14, 341 (1986), Andersson, T., et al.: Brit. J. Clin. Pharmacol., 36, 521 (1993),<br></p>Formula:C16H17N3O2SColor and Shape:NeatMolecular weight:315.39rac Dihydro Mebendazole
CAS:<p>Applications The reduced metabolite of Mebendazole (M200500).<br>References Facino, R., et al.: Biol. Mass Spectrom, 21, 195 (1992), Iosifidou, E., et al.: Drug Metab. Dispos., 25, 317 (1997), De Ruyck, H., et al.: J. Agric. Food Chem., 49, 610 ( 2001),<br></p>Formula:C16H15N3O3Color and Shape:Light YellowMolecular weight:297.314-Methoxy-2-nitroaniline(2-Nitro-p-anisidine)
CAS:Controlled Product<p>Applications Toxic to some wild and domestic birds and mice. Molluscicidal activity<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References De Abreu, F. et al.; Bioorg. Med. Chem. 9, 659 (2001); Schafer, E.W. et al.; Arch. Environ. Con. Tox. 14, 111 (1985); Schafer, E.W. et al.; Arch. Environ. Con. Tox. 12, 355 (1983)<br></p>Formula:C7H8N2O3Color and Shape:NeatMolecular weight:168.153-Cyclobutyl-1H-indazole
CAS:Purity:>95%Color and Shape:Liquid, No data available.Molecular weight:172.2310028076172N-[3-(1H-imidazol-1-yl)propyl]-4,5-dimethyl-1,3-benzothiazol-2-amine
CAS:Purity:95.0%Molecular weight:286.3999938964844(R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid
CAS:Controlled Product<p>Applications An impurity of the anti-convulsant (S)-Pregabalin (P704790).<br>References Lin, S. et al.: J. Liq. Chrom. Rel. Technol., 19, 2699 (1996); Sripathi, S. et al.: ARKIVOC, 10, 266 (2010);<br></p>Formula:C9H17NO3Color and Shape:White To Off-WhiteMolecular weight:187.245-Methyl-2-phenoxypyridine
CAS:Controlled ProductFormula:C12H11NOColor and Shape:NeatMolecular weight:185.23Miconazole Impurity H
CAS:Controlled Product<p>Impurity Miconazole EP Impurity H<br>Applications Miconazole Impurity H (Miconazole EP Impurity H), is the impurity of Miconazole (M342500), which is an imidazole antifungal agent, that is applied topically to the skin or to mucus membranes for the treatment of fungal infections.<br>References Godefroi, E.F., et al.: J. Med. Chem., 12, 784 (1969), Brugmans, et al.: Arch. Dermatol., 102, 428 (1970), Heel, R.C., et al.: Drugs, 19, 7 (1980),<br></p>Formula:C18H16Cl2N2OColor and Shape:NeatMolecular weight:347.241-methyl-1,4-dihydro-5H-tetrazol-5-one
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:100.08100128173828rac 5-Hydroxymethyl Tolterodine-d14
CAS:Controlled ProductFormula:C22H17D14NO2Purity:90%Color and Shape:NeatMolecular weight:355.571,4-Bis(5-phenyloxazol-2-yl)benzene
CAS:Purity:95.0%Color and Shape:Solid, Slightly pale yellow - Pale yellow greenMolecular weight:364.403991699218752,4-Diiodo-1H-imidazole
CAS:Purity:97.0%Color and Shape:Solid, Off-white to pale yellow solidMolecular weight:319.872009277343751-(Tetrahydro-2H-pyran-2-yl)-1H-indazol-4-amine
CAS:Purity:95.0%Color and Shape:Liquid, No data available.Molecular weight:217.272003173828126-ethyl-N-[3-(1H-imidazol-1-yl)propyl]-1,3-benzothiazol-2-amine
CAS:Purity:95.0%Molecular weight:286.3999938964844Oxcarbazepine
CAS:<p>Applications A metabolite of Eslicarbazepine acetate, (BIA 2-093), a novel central nervous system drug. A keto derivative of Carbamazepine. Used as an anticonvulsant. Neuroprotective & Neuroresearch Product.<br>References Dam., M., et al.: Epilepsy Res., 3, 70 (1989); Beydoun, A., et al.: Expert Opin. Pharmacother., 3, 59 (2001);<br></p>Formula:C15H12N2O2Color and Shape:Light YellowMolecular weight:252.27Albendazole Sulfone-d7
CAS:Controlled Product<p>Applications Albendazole Sulfone-d7 is the isotope labelled metabolite of Albendazole (A511610), an anthelmintic agent.<br>References Dominguez, L., et al.: Farmaco, 50, 697 (1995), De Laurentis, N., et al.: Pharm. Pharmacol. Lett., 6, 2: 51 (1996)<br></p>Formula:C12H8D7N3O4SColor and Shape:NeatMolecular weight:304.372,3-Bis(4-methoxyphenyl)-5-phenyl-2H-tetrazol-3-ium chloride
CAS:Purity:98%Molecular weight:394.8599853515625Diethyl Rivastigmine
CAS:Controlled Product<p>Applications An impurity in Rivastigmine (R541000), a cholinesterase inhibitor.<br>References Tse, F., et al.: Pharm. Res., 15, 1614 (1998), Melchiorre, C., et al.: J. Med. Chem., 47, 5945 (2004), Srinivasu, M., et al.: J. Pharm. Biomed. Anal., 37, 57 (2005),<br></p>Formula:C15H24N2O2Color and Shape:NeatMolecular weight:264.3633Nimorazole
CAS:Controlled Product<p>Applications Nimorazole is an antimicrobial with activity against anaerobic bacteria and protozoa.<br>References Ratnaparkhi, M.P., et al.: Res. J. Pharma. BIol. Chem. Sci., 3, 303 (2012); Toustrup, K., et al.: Radiotherap. Oncol., 102, 122 (2012);<br></p>Formula:C9H14N4O3Color and Shape:NeatMolecular weight:226.232-Nitroaniline
CAS:Controlled Product<p>Impurity Albendazole Impurity 4<br>Applications 2-Nitroaniline, is the main precursor to phenylenediamines, which are converted to benzimidazoles, a family of heterocycles that are key components in pharmaceuticals. Albendazole Impurity 4<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Booth, G.,et al.: Ull. Encyc. Indust. Chem. (2007);<br></p>Formula:C6H6N2O2Color and Shape:NeatMolecular weight:138.125-(S-Methyl) Albendazole
CAS:<p>Impurity Albendazole EP Impurity F<br>Applications 5-(S-Methyl) Albendazole is a metabolite of Albendazole (A511610). Albendazole EP Impurity F<br>References Gyurik, R.J., et al.: Drug Metab. Dispos., 9, 503 (1981),<br></p>Formula:C10H11N3O2SColor and Shape:NeatMolecular weight:237.282-cyclohexyl-1H-1,3-benzodiazole-4-carboxylic acid
CAS:Purity:95.0%Color and Shape:Liquid, No data available.Molecular weight:244.29400634765625Tinidazole-d5
CAS:Controlled Product<p>Applications Labelled Tinidazole. Antiprotozoal (Trichomonas, Giardia); antiamebic; antibacterial.<br>References Miller, M.W., et al.: J. Med. Chem., 13, 849 (1970), Oderdea, G., et al.: Gut, 33, 1328 (1992),<br></p>Formula:C8H8D5N3O4SColor and Shape:NeatMolecular weight:252.3Bis(4-cyanophenyl)methanol
CAS:Controlled Product<p>Stability Light Sensitive<br>Applications A metabolite of Letrozole.<br>References Koyama, E., et al.: Ther. Drug Monit., 15, 224 (1993), Pfister, C., et al.: J. Pharm. Sci., 83, 520 (1994), Vander H.Y., et al.: J. Pharm. Biomed. Anal., 24, 723 (2001), Cohen, M., et al.: Clin. Cancer Res., 8, 665 (2002),<br></p>Formula:C15H10N2OColor and Shape:NeatMolecular weight:234.25ETHYL 1-CYCLOHEXYL-2-(FURAN-3-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE
CAS:Purity:95.0%Molecular weight:338.40701293945312,4-Dihydro-4-[4-[4-(4-hydroxyphenyl]-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
CAS:Controlled Product<p>Applications An intermediate in the synthesis of Itraconazole.<br></p>Formula:C22H27N5O2Color and Shape:NeatMolecular weight:393.48Albendazole Sulfone
CAS:<p>Impurity Albendazole EP Impurity C / Albendazole Sulfone<br>Applications A metabolite of Albendazole, an anthelmintic. Albendazole EP Impurity C<br>References Dominguez, L., et al.: Farmaco, 50, 697 (1995), De Laurentis, N., et al.: Pharm. Pharmacol. Lett., 6, 2: 51 (1996)<br></p>Formula:C12H15N3O4SColor and Shape:BeigeMolecular weight:297.33Scopolamine N-Oxide
CAS:<p>Stability Hygroscopic<br>Applications Scopolamine N-Oxide is an impurity of Scopolamine (S200000), an acetylcholine antagonist used in the treatment of motion sickness and also used as antiemetic, antispasmodic, mydriatic, preanesthetic agents.<br>References Shahwar, D., et al.: Turk. J. Chem., 36, 257 (2012); Paula, S., et al.: J. Med. Chem., 47, 133 (2004); Wu, H.L., et al.: J. Chromatograph. A., 802, 107 (1998); Phillipson, J.D., et al.: J. Pharma. Pharmcol., 25, 116 (1973);<br></p>Formula:C17H21NO5Color and Shape:NeatMolecular weight:319.35Modafinil-d10 Carboxylate
CAS:Controlled Product<p>Applications A metabolite of Modafinil, a central nervous system vigilance promoting agent, which possesses neuroprotective properties.<br>References Duteil, J., et al.: Eur. J. Pharmacol., 180, 49 (1990), Wong, Y., et al.: J. Clin. Pharmacol., 317, 30 (1999), Robertson, P., et al.: Drug Disp., 42, 123 (2003)<br></p>Formula:C15H4D10O3SColor and Shape:NeatMolecular weight:284.4Atropic Acid
CAS:<p>Impurity Ipratropium EP Impurity D<br>Stability Light Sensitive<br>Applications Atropic acid (Ipratropium EP Impurity D) is an impurity of Ipratropium bromide (I740500) and Atropine Sulfate (A794625).<br>References Lyon, R., et al.: J. Pharm. Sci., 95, 1549 (2006), Loch, M., et al.: Toxicology, 233, 229 (2007), John, H., et al.: Anal. Bioanal. Chem., 396, 751 (2010),<br></p>Formula:C9H8O2Color and Shape:Off-WhiteMolecular weight:148.16(R)-Rabeprazole Sodium Salt
CAS:Controlled Product<p>Applications A partially reversible gastric proton pump inhibitor.<br>References Moda, T., et al.: Lett. Drug Des. Discov., 4, 502 (2007), Belaz, K., et al.: J. Pharm. Biomed. Anal., 47, 81 (2008),<br></p>Formula:C18H20N3NaO3SColor and Shape:NeatMolecular weight:381.42Luliconazole
CAS:Controlled Product<p>Stability Light Sensitive<br>Applications Luliconazole is an azole antifungal drug.<br>References Uhida, K., et al.: J. Infect. Chemother., 10, 216 (2004); Niwano, ., et al.: Antimicro. Agents Chemother., 42, 967 (1998),<br></p>Formula:C14H9Cl2N3S2Color and Shape:Off-White To Light YellowMolecular weight:354.28Rufinamide-15N,d2
CAS:Controlled Product<p>Applications Labelled Rufinamide (R701552). Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant.<br>References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),<br></p>Formula:C10H6D2F2N315NOColor and Shape:White SolidMolecular weight:241.2Hydroxy Itraconazole
CAS:Controlled Product<p>Applications A metabolite of Itraconazole, an orally active antimycotic structurally related to Ketoconazole. It is a COVID19-related research product.<br>References Saag, M., et al.: Antimicrob. Agents Chemother., 32, 1 (1988), Haria, M., et al.: Drugs, 51, 585 (1996), Kousoulos, C., et al.: Anal. Bioanal. Chem., 384,199 (2006),<br></p>Formula:C35H40Cl2N8O4Color and Shape:WhiteMolecular weight:707.653-Dechloro-4-chloro Lamotrigine
CAS:Controlled Product<p>Impurity Lamotrigine EP Impurity G<br>Applications 3-Dechloro-4-chloro Lamotrigine (Lamotrigine EP Impurity G) is a potential impurity of Lamotrigine (L173250).<br>References Rees, R., et al.: J. Med. Chem., 15, 859 (1972), McNamara, J., et al.: Nature, 399, A15 (1999),<br></p>Formula:C9H7Cl2N5Color and Shape:NeatMolecular weight:256.09Lansoprazole Sulfone-d4
CAS:Controlled ProductFormula:C16H10D4F3N3O3SColor and Shape:NeatMolecular weight:389.38Lansoprazole N-Oxide
CAS:Controlled Product<p>Impurity Lansoprazole EP Impurity A<br>Applications Lansoprazole N-Oxide (Lansoprazole EP Impurity A) is an impurity of Lansoprazole (L175000) formed during the bulk synthesis of the drug.<br>References Kubo, K., et al.: Chem. Pharm. Bull., 38, 2853 (1990), Barradell, L., et al.: Drugs, 44, 225 (1992), Aydogmus, Z., et al.: Acta Pharm. Sci., 48, 45 (2006),<br></p>Formula:C16H14F3N3O3SColor and Shape:NeatMolecular weight:385.36
![N-[3-(1H-imidazol-1-yl)propyl]-4,5-dimethyl-1,3-benzothiazol-2-amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF495558.webp&w=3840&q=75)
![6-ethyl-N-[3-(1H-imidazol-1-yl)propyl]-1,3-benzothiazol-2-amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF495565.webp&w=3840&q=75)
![ETHYL 1-CYCLOHEXYL-2-(FURAN-3-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF388803.webp&w=3840&q=75)
![2,4-Dihydro-4-[4-[4-(4-hydroxyphenyl]-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD449140.webp&w=3840&q=75)
